Hepatitis A and typhoid vaccine
| Combination of | |
|---|---|
| Hepatitis A | Vaccine |
| Typhoid | Vaccine |
| Clinical data | |
| Trade names | ViVaxim, Hepatyrix, ViATIM |
| AHFS/Drugs.com | UK Drug Information |
| Routes of administration | Intramuscular injection |
| ATC code | |
| Identifiers | |
| ChemSpider |
|
Hepatitis A and typhoid vaccine is a combination vaccine to protect against the infectious diseases hepatitis A and typhoid. It is a combination of inactivated Hepatitis A virus and Vi polysaccharide of Salmonella typhi bacteria. Branded formulations include Hepatyrix from GlaxoSmithKline,[1][2] and ViVaxim[3] and ViATIM[4] from Sanofi Pasteur.[1]
References
- 1 2 "List of nationally authorised medicinal products. Active substance(s): hepatitis a (inactivated) / typhoid polysaccharide vaccine (adsorbed)". European Medicines Agency. Retrieved 15 July 2018.
- ↑ "Hepatyrix. Package Leaflet:Information for the user" (PDF). Drugs.com. Retrieved 15 July 2018.
- ↑ "VIVAXIM SUSPENSION AND SOLUTION FOR SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE". Drugs.com. Retrieved 15 July 2018.
- ↑ "VIATIM SUSPENSION AND SOLUTION FOR SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE". Drugs.com. Retrieved 15 July 2018.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.